PL1601646T3 - Analogi 2-podstawionej witaminy D i ich zastosowania terapeutyczne - Google Patents

Analogi 2-podstawionej witaminy D i ich zastosowania terapeutyczne

Info

Publication number
PL1601646T3
PL1601646T3 PL04718886T PL04718886T PL1601646T3 PL 1601646 T3 PL1601646 T3 PL 1601646T3 PL 04718886 T PL04718886 T PL 04718886T PL 04718886 T PL04718886 T PL 04718886T PL 1601646 T3 PL1601646 T3 PL 1601646T3
Authority
PL
Poland
Prior art keywords
analogues
vitamin
therapeutic uses
substituted vitamin
alkyl
Prior art date
Application number
PL04718886T
Other languages
English (en)
Inventor
Roger Bouillon
Annemieke Verstuyf
Maurits Vandewalle
Clercq Pierre De
Original Assignee
K U Leuven Res And Development
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K U Leuven Res And Development, Univ Gent filed Critical K U Leuven Res And Development
Publication of PL1601646T3 publication Critical patent/PL1601646T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04718886T 2003-03-10 2004-03-10 Analogi 2-podstawionej witaminy D i ich zastosowania terapeutyczne PL1601646T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305332.9A GB0305332D0 (en) 2003-03-10 2003-03-10 Biological evaluation of novel vitamin D analogues
EP04718886A EP1601646B1 (en) 2003-03-10 2004-03-10 2-substituted vitamin d analogues and their therapeutic uses
PCT/BE2004/000037 WO2004080922A2 (en) 2003-03-10 2004-03-10 Substituted vitamin d analogues and their therapeutic uses

Publications (1)

Publication Number Publication Date
PL1601646T3 true PL1601646T3 (pl) 2011-12-30

Family

ID=9954381

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04718886T PL1601646T3 (pl) 2003-03-10 2004-03-10 Analogi 2-podstawionej witaminy D i ich zastosowania terapeutyczne

Country Status (14)

Country Link
US (1) US20060189576A1 (pl)
EP (1) EP1601646B1 (pl)
JP (1) JP2006519788A (pl)
AT (1) ATE517864T1 (pl)
AU (1) AU2004220477B8 (pl)
CA (1) CA2518531A1 (pl)
CY (1) CY1111843T1 (pl)
DK (1) DK1601646T3 (pl)
ES (1) ES2368064T3 (pl)
GB (1) GB0305332D0 (pl)
PL (1) PL1601646T3 (pl)
PT (1) PT1601646E (pl)
SI (1) SI1601646T1 (pl)
WO (1) WO2004080922A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2588399A1 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
DE602005021538D1 (de) 2004-11-22 2010-07-08 Wisconsin Alumni Res Found 17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen
US7241749B2 (en) 2004-11-22 2007-07-10 Wisconsin Alumni Research Foundation 2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses
WO2006060885A1 (en) * 2004-12-07 2006-06-15 K.U.Leuven Research & Development 7-(2-cyclohexylidene-ethylidene)-spiro[5.5]undecanes useful for making pharmaceutical compositions
NZ563758A (en) 2005-05-03 2010-04-30 Wisconsin Alumni Res Found 19,26,27-Trinor-1alpha,25-dihydroxyvitamin D3 compounds
US7803789B2 (en) 2006-02-02 2010-09-28 Wisconsin Alumni Research Foundation Vitamin D analog—RAK, methods and uses thereof
US7528122B2 (en) 2006-02-02 2009-05-05 Wisconsin Alumni Research Foundation Vitamin D analog—NEL, methods and uses thereof
JP2009532460A (ja) 2006-04-06 2009-09-10 ウイスコンシン アラムニ リサーチ ファンデーション ２−置換−１α，２５−ジヒドロキシ−１９，２６，２７−トリノルビタミンＤ類縁体およびその使用
MX2008012913A (es) 2006-04-06 2009-03-06 Wisconsin Alumni Res Found 2-metilen-1a,25-dihidroxi-18,19,21-trinorvitamina d3 y sus usos.
CA2648324A1 (en) 2006-04-06 2007-10-18 Wisconsin Alumni Research Foundation 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
MX2009003241A (es) 2006-09-28 2009-05-05 Wisconsin Alumni Res Found Analogos de 2-metilen-(20r,25s)-19,27-dinor-(22e)-vitamina d.
ATE505194T1 (de) * 2009-05-20 2011-04-15 Hybrigenics Sa Neue therapeutische verwendungen von inecalcitol
EP2490695B1 (en) * 2009-10-21 2013-11-20 Wisconsin Alumni Research Foundation Method of preventing type 1 diabetes
EP2407152A1 (en) 2010-07-15 2012-01-18 Hybrigenics S.A. Formulations of 14-epi-analogues of vitamin D
AU2011278346B2 (en) 2010-07-15 2016-04-07 Hybrigenics Sa New formulations of 14 - epi -analogues of vitamin D
US20120015913A1 (en) * 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
WO2012118154A1 (ja) 2011-03-02 2012-09-07 学校法人日本大学 パーシャルアゴニスト活性を持つ新規ビタミンd受容体モジュレーター
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
CA2964463C (en) 2014-10-22 2024-02-13 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
CN104326922B (zh) * 2014-11-03 2016-08-17 成都百裕制药股份有限公司 替格瑞洛中间体(1r,2s)-2-(2,3-二氟苯基)环丙胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
ES2147238T3 (es) * 1993-07-09 2000-09-01 Theramex Nuevos analogos estructurales de la vitamina d.
US5936105A (en) * 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
IL152942A (en) * 2000-05-31 2007-09-20 Wisconsin Alumni Res Found Compounds 2 - Ethyl and 2 - Ethylaidine - 19 - Nur - Vitamin D and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
WO2004080922A3 (en) 2004-12-09
SI1601646T1 (sl) 2011-11-30
ATE517864T1 (de) 2011-08-15
AU2004220477B8 (en) 2010-10-14
CA2518531A1 (en) 2004-09-23
AU2004220477B2 (en) 2010-05-06
ES2368064T3 (es) 2011-11-14
WO2004080922A2 (en) 2004-09-23
GB0305332D0 (en) 2003-04-09
US20060189576A1 (en) 2006-08-24
JP2006519788A (ja) 2006-08-31
AU2004220477A1 (en) 2004-09-23
EP1601646B1 (en) 2011-07-27
CY1111843T1 (el) 2015-10-07
EP1601646A2 (en) 2005-12-07
PT1601646E (pt) 2011-09-16
DK1601646T3 (da) 2011-10-03

Similar Documents

Publication Publication Date Title
CY1111843T1 (el) 2-υποκατεστημενα αναλογα βιταμινης d και θεραπευτικες χρησεις αυτων
RS20050363A (en) Chk-,pdk-and akt-inhibitory pyrimidines,their production an use as pharmaceutical agents
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
UY28121A1 (es) Activadores de glucoquinasa heteroaromaticos de seis miembros 5-sustituidos
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
BR0207846A (pt) Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
CR10974A (es) Inhibidores de carboxipeptidasa b plasmatica (divisional)
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
MX2009002998A (es) Derivado de pirazolopirimidina.
SG145570A1 (en) 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
TW200628153A (en) Novel compounds
HK1075663A1 (en) Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a sb 2 /sb
UY26298A1 (es) "derivados de bencimidazol sustituidos con aminocarbonilo, procedimientos para su preparación y su utilización como medicamentos."
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
BRPI0207102A8 (pt) forma cristalina, composição farmacêutica, e, uso de uma forma cristalina.
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
DK1451182T3 (da) Dimere forbindelser og deres anvendelse som antivirale midler
PL1628662T3 (pl) Pochodne benzotiazolu i ich zastosowanie w leczeniu chorób związanych z receptorem adenozynowym A2A
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
RS20050421A (en) Aminoindazole derivatives and use thereof as kinase inhibitors